262 related articles for article (PubMed ID: 10875856)
1. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
Peñarrubia J; Balasch J; Fábregues F; Carmona F; Casamitjana R; Moreno V; Calafell JM; Vanrell JA
Hum Reprod; 2000 Jul; 15(7):1499-504. PubMed ID: 10875856
[TBL] [Abstract][Full Text] [Related]
2. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
3. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
[TBL] [Abstract][Full Text] [Related]
4. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.
Creus M; Peñarrubia J; Fábregues F; Vidal E; Carmona F; Casamitjana R; Vanrell JA; Balasch J
Hum Reprod; 2000 Nov; 15(11):2341-6. PubMed ID: 11056129
[TBL] [Abstract][Full Text] [Related]
5. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.
Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Ascaso C; Vanrell JA
Am J Obstet Gynecol; 1996 Nov; 175(5):1226-30. PubMed ID: 8942492
[TBL] [Abstract][Full Text] [Related]
6. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
[TBL] [Abstract][Full Text] [Related]
7. Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction.
Balasch J; Peñarrubia J; Fábregues F; Vidal E; Casamitjana R; Manau D; Carmona F; Creus M; Vanrell JA
Reprod Biomed Online; 2003; 7(1):35-42. PubMed ID: 12930572
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
10. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
Peñarrubia J; Fábregues F; Creus M; Manau D; Casamitjana R; Guimerá M; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2003 Dec; 18(12):2689-97. PubMed ID: 14645193
[TBL] [Abstract][Full Text] [Related]
11. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
Westergaard LG; Yding Andersen C; Erb K; Laursen SB; Rasmussen PE; Rex S; Teisner B
Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294
[TBL] [Abstract][Full Text] [Related]
12. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
[TBL] [Abstract][Full Text] [Related]
13. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
14. Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.
Miao MF; Huang HF
J Zhejiang Univ Sci B; 2009 Jan; 10(1):35-45. PubMed ID: 19198021
[TBL] [Abstract][Full Text] [Related]
15. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
16. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
Urbancsek J; Hauzman EE; Murber A; Lagarde AR; Rabe T; Papp Z; Strowitzki T
Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
[TBL] [Abstract][Full Text] [Related]
17. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
18. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
20. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.
Erdem M; Erdem A; Gursoy R; Biberoglu K
J Assist Reprod Genet; 2004 Feb; 21(2):37-45. PubMed ID: 15186020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
